EVENTS
VaDrugDiscoveryRx 2022: Cardiovascular, Pulmonary, and Metabolic Disease
VaDDRx 2022 will feature lectures from leaders in the fields of cardiovascular, pulmonary, and metabolic disease.
Virginia Drug Discovery Consortium
The Virginia Drug Discovery Consortium (VaDDC) has a threefold mission:
To promote the growth and advancement of drug discovery and development programs at universities and research institutes within Virginia, particularly through inter-institutional collaboration.
To help the pharmaceutical industry bring life-saving and quality of life solutions to patients through innovative collaborations with Virginia’s best and brightest researchers.
To promote and enhance the attractiveness of Virginia as an environment for pharmaceutical and biotech companies.
NEWS
Exec. Committee Member Beth Sharlow on UVA’s Fiske Drug Discovery Lab
Elizabeth R. Sharlow, Professor of Research, Pharmacology in University of Virginia's School of Medicine discusses UVA's Fiske Drug Discovery Laboratory where impactful pharmacological research occurs every day. UVA graduate and undergraduate students are learning to...
KeViRx Selected as Part of BLUE KNIGHT™ Collaboration for Global Health Preparedness
Charlottesville, Virginia - February 2022 KeViRx, Inc. (“KeViRx”) has been selected to join Blue Knight, a joint initiative between Johnson & Johnson Innovation – JLABS and the Biomedical Advanced Research and Development Authority (BARDA), a component of the U.S....
Desai Grant on Factor XIa Inhibitors Funded
Umesh Desai, VaDDC executive committee member and chair of Virginia Commonwealth University's medicinal chemistry department, has just received an R61/33 grant to develop allosteric inhibitors of coagulation factor XIa. The grant, titled "Lead Identification and...
AFFILIATES
Want to work with us?
If you are interested in supporting this initiative, please contact us.